A receptor for activated C3 in the human renal glomerular capillary wall
Gelfand, M.C.; Frank, M.M.; Nagle, R.; Shin, M.; Green, I.
Proceedings of the Clinical Dialysis and Transplant Forum 5(7): 102-105
1975
ISSN/ISBN: 0094-6044 PMID: 785448 Document Number: 88278
Double blind study with contralateral comparison, between diflucortolon valerianat, 0.1% and the flumetason pivalat, 0.02% in pomades (ointments). Selection of 52 patients both sexes and variable ages with bilateral dermatological inflamatory lesions and with simetric preference: Psoriasis, "eczema vario" and neurodermatitis. In psoriasis, diflucortolon offered better results: the same occurred in the cases of eczema, and in neurodermatitis. The efficacy was similar. There were no appearances of negative secondary effects because of the used doses and time.